Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
528
relevant articles (4 outcomes,
36 trials/studies)
found for this Disease
Description:
A heterogeneous group of autosomal inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.
Also Known As:
Syndrome, Ehlers-Danlos; Ehlers-Danlos Disease; Ehlers-Danlos Syndrome, Type IV; Ehlers-Danlos Syndrome, Vascular Type; Disease, Ehlers-Danlos; Ehlers Danlos Disease; Ehlers Danlos Syndrome; Ehlers Danlos Syndrome, Type IV; Ehlers Danlos Syndrome, Vascular Type; Cutis Elastica
Relationship Network
Disease Context: Research Results
Related Diseases
Experts
| 1. | Schalkwijk, J:
5 articles
(09/2007 - 10/2001)
|
| 2. | Bristow, J:
4 articles
(04/2005 - 05/2001)
|
| 3. | Walker, L C:
4 articles
(12/2004 - 02/2000)
|
| 4. | Schwarze, Ulrike:
3 articles
(06/2008 - 08/2002)
|
| 5. | Steinmann, Beat:
3 articles
(06/2008 - 07/2002)
|
| 6. | Marini, Joan C:
3 articles
(04/2007 - 05/2005)
|
| 7. | Makareeva, Elena:
3 articles
(04/2007 - 05/2005)
|
| 8. | Leikin, Sergey:
3 articles
(04/2007 - 05/2005)
|
| 9. | Cabral, Wayne A:
3 articles
(04/2007 - 05/2005)
|
| 10. | Bristow, James:
3 articles
(11/2005 - 04/2002)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Ehlers-Danlos Syndrome: